Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets (Details)

v3.23.3
Schedule of Deferred Tax Assets (Details) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 2,866,860 $ 1,843,175
Other assets and liabilities 272,162 265,741
Stock- based compensation 298,135 120,576
Capitalized research and development expenditures 1,248,760
Gross deferred tax assets 4,685,917 2,229,492
Valuation allowance (4,685,917) (2,229,492)
Total deferred tax assets, net of valuation allowance